Literature DB >> 27701937

Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus.

J Calderón1, P Flores1, J M Aguirre1, G Valdivia2, O Padilla2, I Barra3, L Scoriels4, S Herrera3, A González5,6, L Massardo5.   

Abstract

OBJECTIVES: To define the relative role of cognitive impairment, depression, disease activity, and disease damage in the decreased health-related quality of life (HRQoL) frequently observed in systemic lupus erythematosus (SLE) patients.
METHOD: We studied 101 Chilean female SLE patients and applied the 12-item Medical Outcomes Study (MOS) Short Form Health Survey version 2 (SF-12v2) to assess HRQoL and the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess cognitive function. Analysis of covariance (ANCOVA) models included demographic and disease-related factors and cognitive function tests of sustained attention, memory, and executive function.
RESULTS: All measures of HRQoL were lower in the 101 female SLE patients compared to the women from the Chilean general population. HRQoL was associated with the following factors: (i) depression symptoms, which were detrimental to all components of the physical and mental HRQoL scores; (ii) executive dysfunction (spatial planning), which was associated with lower scores on role limitations due to physical health problems and emotional problems, and general health perceptions; (iii) higher activity and organ damage were deleterious to role physical, bodily pain, and physical summary scores; and (iv) higher damage also impacted physical function. Impairments in sustained attention and memory did not decrease the HRQoL.
CONCLUSIONS: Our results highlight the relevance of executive dysfunction to poor physical and mental health components of HRQoL in SLE together with depression, while disease activity and disease damage are associated with lower HRQoL physical components. The need for cognitive function evaluation and rehabilitation in SLE is indicated.

Entities:  

Mesh:

Year:  2016        PMID: 27701937     DOI: 10.1080/03009742.2016.1206617

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  13 in total

1.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

Authors:  Meggan Mackay; An Vo; Chris C Tang; Michael Small; Erik W Anderson; Elisabeth J Ploran; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce T Volpe; Betty Diamond; David Eidelberg
Journal:  JCI Insight       Date:  2019-01-10

2.  Predictors of damage accrual in systemic lupus erythematosus: a longitudinal observational study with focus on neuropsychological factors and anti-neuronal antibodies.

Authors:  Milena Mimica; Ignacio Barra; Rocío Ormeño; Patricia Flores; Jorge Calderón; Oslando Padilla; Marcela Bravo-Zehnder; Alfonso González; Loreto Massardo
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

3.  Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.

Authors:  J M Chi; M Mackay; A Hoang; K Cheng; C Aranow; J Ivanidze; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-21       Impact factor: 3.825

4.  Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.

Authors:  Courtney Hoge; C Barrett Bowling; S Sam Lim; Cristina Drenkard; Laura C Plantinga
Journal:  J Rheumatol       Date:  2020-03-01       Impact factor: 4.666

5.  Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patients.

Authors:  Qiu-Yue Lou; Zhen Li; Ying Teng; Qiao-Mei Xie; Man Zhang; Shun-Wei Huang; Wen-Fei Li; Yang-Fan Chen; Fa-Ming Pan; Sheng-Qian Xu; Jing Cai; Shuang Liu; Jin-Hui Tao; Sheng-Xiu Liu; Hai-Liang Huang; Fang Wang; Hai-Feng Pan; Hong Su; Zhi-Wei Xu; Wen-Biao Hu; Yan-Feng Zou
Journal:  Clin Rheumatol       Date:  2020-06-16       Impact factor: 2.980

6.  Quality of life among female patients with systemic lupus erythematosus in remission.

Authors:  Rudra Prosad Goswami; Rudrani Chatterjee; Parasar Ghosh; Geetabali Sircar; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2019-05-25       Impact factor: 3.580

7.  Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance.

Authors:  Elisabeth Ploran; Chris Tang; Meggan Mackay; Michael Small; Erik Anderson; Justin Storbeck; Brittany Bascetta; Simran Kang; Cynthia Aranow; Carl Sartori; Philip Watson; Bruce Volpe; Betty Diamond; David Eidelberg
Journal:  Lupus Sci Med       Date:  2019-07-11

8.  Pathways linking census tract typologies with subjective neighborhood disorder and depressive symptoms in the Black Women's Experiences Living with Lupus (BeWELL) Study.

Authors:  Connor D Martz; Evelyn A Hunter; Michael R Kramer; Yijie Wang; Kara Chung; Michael Brown; Cristina Drenkard; S Sam Lim; David H Chae
Journal:  Health Place       Date:  2021-06-09       Impact factor: 4.931

9.  Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG.

Authors:  Sofía Espinoza; Sebastián B Arredondo; Francisca Barake; Francisco Carvajal; Fernanda G Guerrero; Fabian Segovia-Miranda; David M Valenzuela; Ursula Wyneken; Alejandro Rojas-Fernández; Waldo Cerpa; Loreto Massardo; Lorena Varela-Nallar; Alfonso González
Journal:  BMC Biol       Date:  2020-11-06       Impact factor: 7.431

10.  Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Alvaro Gomez; Fawz Hani Butrus; Petter Johansson; Emil Åkerström; Sofia Soukka; Sharzad Emamikia; Yvonne Enman; Susanne Pettersson; Ioannis Parodis
Journal:  Rheumatology (Oxford)       Date:  2021-03-02       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.